Welcome to LookChem.com Sign In|Join Free
  • or
Pyrido[3,4-d]pyridazin-5(6H)-one (9CI) is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

125968-89-0

Post Buying Request

125968-89-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

125968-89-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 125968-89-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,2,5,9,6 and 8 respectively; the second part has 2 digits, 8 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 125968-89:
(8*1)+(7*2)+(6*5)+(5*9)+(4*6)+(3*8)+(2*8)+(1*9)=170
170 % 10 = 0
So 125968-89-0 is a valid CAS Registry Number.

125968-89-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 6H-pyrido[3,4-d]pyridazin-5-one

1.2 Other means of identification

Product number -
Other names Pyrido[3,4-d]pyridazin-5(6H)-one (9CI)

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:125968-89-0 SDS

125968-89-0Downstream Products

125968-89-0Relevant academic research and scientific papers

NAPHTHYRIDINE DERIVATIVES AS PRC2 INHIBITORS

-

Paragraph 0227-0228, (2020/11/03)

Disclosed are compounds of formula (I) or (II) that inhibit Polycomb Repressive Complex 2 (PRC2) activity. In particular, the present invention relates to compounds, pharmaceutical compositions and methods of use, such as methods of treating cancer using the compounds and pharmaceutical compositions of the present invention.

Pyridazines. XLI Synthesis of Novel Pyridopyridazine Derivatives from 4,5-Disubstituted Pyridazines

Boamah, Philip Yaw,Haider, Norbert,Heinisch, Gottfried

, p. 933 - 939 (2007/10/02)

Pyridopyridazines 2-5, 21 bearing one, two, or three aryl substituents in the pyridine moiety are shown to be conveniently accessible from 4-aroyl-5-methylpyridazines or 4,5-diaroylpyridazines, respectively, by condensation reactions with appropriate C-N fragments.In addition, the novel pyridazine-annelated pyridones 24, 25 were found to be easily available from ethyl 5-methyl-4-pyridazinecarboxylate.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 125968-89-0